Linda Solferino is a Cambridge, Massachusetts based nurse practitioner. Active license number of Linda Solferino is RN281100 in Massachusetts. Her current practice location is 725 Concord Ave, Cambridge. Patients can reach her at 617-864-8822. Linda Solferino is NP and her NPI number (Unique professional ID assigned by NPPES) is 1538500293. Linda Solferino has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Linda Solferino speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1538500293
NPI Enumeration Date:
10 Jul, 2013
NPI Last Update On:
16 Oct, 2018
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Linda Solferino are as mentioned below.
License Number
Specialization
State
Status
RN281100
Massachusetts
Primary
RN281100
Registered Nurse
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Linda Solferino 725 Concord Ave, Cambridge, Massachusetts
Zip:
02138-1040
Phone Number:
617-864-8822
Patients can reach Linda Solferino at 725 Concord Ave, Cambridge, Massachusetts or can call to book an appointment on 617-864-8822.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.